Literature DB >> 22552889

Role of a DNA damage checkpoint pathway in ionizing radiation-induced glioblastoma cell migration and invasion.

Issai Vanan1, Zhiwan Dong, Elena Tosti, Gregg Warshaw, Marc Symons, Rosamaria Ruggieri.   

Abstract

Ionizing radiation (IR) induces a DNA damage response that includes activation of cell cycle checkpoints, leading to cell cycle arrest. In addition, IR enhances cell invasiveness of glioblastoma cells, among other tumor cell types. Using RNA interference, we found that the protein kinase MRK, previously implicated in the DNA damage response to IR, also inhibits IR-induced cell migration and invasion of glioblastoma cells. We showed that MRK activation by IR requires the checkpoint protein Nbs1 and that Nbs1 is also required for IR-stimulated migration. In addition, we show that MRK acts upstream of Chk2 and that Chk2 is also required for IR-stimulated migration and invasion. Thus, we have identified Nbs1, MRK, and Chk2 as elements of a novel signaling pathway that mediates IR-stimulated cell migration and invasion. Interestingly, we found that inhibition of cell cycle progression, either with the CDK1/2 inhibitor CGP74514A or by downregulation of the CDC25A protein phosphatase, restores IR-induced migration and invasion in cells depleted of MRK or Chk2. These data indicate that cell cycle progression, at least in the context of IR, exerts a negative control on the invasive properties of glioblastoma cells and that checkpoint proteins mediate IR-induced invasive behavior by controlling cell cycle arrest.

Entities:  

Mesh:

Year:  2012        PMID: 22552889     DOI: 10.1007/s10571-012-9846-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  42 in total

1.  Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.

Authors:  Zhijiu Zhong; Wen-Shuz Yeow; Chunhua Zou; Richard Wassell; Chenguang Wang; Richard G Pestell; Judy N Quong; Andrew A Quong
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.

Authors:  Manuel Stucki; Julie A Clapperton; Duaa Mohammad; Michael B Yaffe; Stephen J Smerdon; Stephen P Jackson
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

3.  Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.

Authors:  Kelly A McClellan; Vladimir A Ruzhynsky; David N Douda; Jacqueline L Vanderluit; Kerry L Ferguson; Danian Chen; Rod Bremner; David S Park; Gustavo Leone; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

4.  Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

Authors:  Sylvie Monferran; Nicolas Skuli; Caroline Delmas; Gilles Favre; Jacques Bonnet; Elizabeth Cohen-Jonathan-Moyal; Christine Toulas
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

Review 5.  MDC1: The art of keeping things in focus.

Authors:  Stephanie Jungmichel; Manuel Stucki
Journal:  Chromosoma       Date:  2010-03-12       Impact factor: 4.316

6.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Gerard Nuovo; Jeff Palatini; Michael De Lay; James Van Brocklyn; Michael C Ostrowski; E Antonio Chiocca; Sean E Lawler
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

7.  MRK, a mixed lineage kinase-related molecule that plays a role in gamma-radiation-induced cell cycle arrest.

Authors:  Eleanore A Gross; Marinella G Callow; Linda Waldbaum; Suzanne Thomas; Rosamaria Ruggieri
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

Review 8.  Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1.

Authors:  Valentina Evdokimova; Cristina Tognon; Tony Ng; Poul H B Sorensen
Journal:  Cell Cycle       Date:  2009-09-16       Impact factor: 4.534

9.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

10.  MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.

Authors:  Aruna Venkata Badiga; Chandramu Chetty; Divya Kesanakurti; Deepthi Are; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

View more
  7 in total

1.  Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.

Authors:  Zhiqin Xu; Wenbin Ma; Lu Gao; Bing Xing
Journal:  Tumour Biol       Date:  2013-11-20

2.  BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.

Authors:  Harina Vin; Sandra S Ojeda; Grace Ching; Marco L Leung; Vida Chitsazzadeh; David W Dwyer; Charles H Adelmann; Monica Restrepo; Kristen N Richards; Larissa R Stewart; Lili Du; Scarlett B Ferguson; Deepavali Chakravarti; Karin Ehrenreiter; Manuela Baccarini; Rosamaria Ruggieri; Jonathan L Curry; Kevin B Kim; Ana M Ciurea; Madeleine Duvic; Victor G Prieto; Stephen E Ullrich; Kevin N Dalby; Elsa R Flores; Kenneth Y Tsai
Journal:  Elife       Date:  2013-11-05       Impact factor: 8.140

Review 3.  Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma.

Authors:  Liesbeth Everix; Shankari Nair; Cathryn H S Driver; Ingeborg Goethals; Mike M Sathekge; Thomas Ebenhan; Charlot Vandevoorde; Julie Bolcaen
Journal:  Cancers (Basel)       Date:  2022-04-03       Impact factor: 6.639

4.  Ionizing radiation, ion transports, and radioresistance of cancer cells.

Authors:  Stephan M Huber; Lena Butz; Benjamin Stegen; Dominik Klumpp; Norbert Braun; Peter Ruth; Franziska Eckert
Journal:  Front Physiol       Date:  2013-08-14       Impact factor: 4.566

Review 5.  Radioresistance of Brain Tumors.

Authors:  Kevin Kelley; Jonathan Knisely; Marc Symons; Rosamaria Ruggieri
Journal:  Cancers (Basel)       Date:  2016-03-30       Impact factor: 6.639

Review 6.  DIPG in Children - What Can We Learn from the Past?

Authors:  Magimairajan Issai Vanan; David D Eisenstat
Journal:  Front Oncol       Date:  2015-10-21       Impact factor: 6.244

7.  Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.

Authors:  J M Loupe; P J Miller; B P Bonner; E C Maggi; J Vijayaraghavan; J S Crabtree; C M Taylor; J Zabaleta; A D Hollenbach
Journal:  Oncogenesis       Date:  2016-07-25       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.